These data are in line with the finding of a tight correlation between expression of NED markers and that of SNAI2 in the clinical samples, and suggest that firm and strong SNAI2 expression promotes NED within high-grade PCa, thus favoring tumor progression along these pathways [14]. The gene discussed is SNAI2; the disease is posterior cortical atrophy.